{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T02:00:18Z","timestamp":1648864818374},"reference-count":27,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,1,31]]},"DOI":"10.1536\/ihj.19-379","type":"journal-article","created":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T17:05:07Z","timestamp":1579194307000},"page":"77-82","source":"Crossref","is-referenced-by-count":0,"title":["Heart is the Target Organ of Endogenous Cardiac Natriuretic Peptides"],"prefix":"10.1536","volume":"61","author":[{"given":"Takayoshi","family":"Tsutamoto","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shiga University of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Kangawa K, Tawaragi Y, Oikawa S, <i>et al<\/i>. Identification of rat gamma atrial natriuretic polypeptide and characterization of the cDNA encoding its precursor. Nature 1984; 312: 152-5.","DOI":"10.1038\/310152a0"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.","DOI":"10.1038\/332078a0"},{"key":"3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","volume":"90","year":"1994","unstructured":"3. Yasue H, Yoshimura M, Sumida H, <i>et al<\/i>. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Maisel AS, Nakao K, Ponikowski P, <i>et al<\/i>. Japanese-Western consensus meeting on biomarkers. Japanese-Western Consensus Meeting on Biomarkers. Int Heart J 2011; 52: 253-65.","DOI":"10.1536\/ihj.52.253"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Clerico A, Recchia FA, Passino C, Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 2006; 290: H17-29.","DOI":"10.1152\/ajpheart.00684.2005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. D\u00edez J. Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy. Eur J Heart Fail 2017; 19: 167-76.","DOI":"10.1002\/ejhf.656"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Tsutamoto T, Wada A, Maeda K, <i>et al<\/i>. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-16.","DOI":"10.1161\/01.CIR.96.2.509"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998; 135: 825-32.","DOI":"10.1016\/S0002-8703(98)70041-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tsutamoto T, Wada A, Maeda K, <i>et al<\/i>. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 1999; 20: 1799-807.","DOI":"10.1053\/euhj.1999.1746"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Maeda K, Tsutamoto T, Wada A, <i>et al<\/i>. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000; 36: 1587-93.","DOI":"10.1016\/S0735-1097(00)00912-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Januzzi JL, van Kimmenade R, Lainchbury J, <i>et al<\/i>. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006; 27: 330-7.","DOI":"10.1093\/eurheartj\/ehi631"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Witteles RM, Kao D, Christopherson D, <i>et al<\/i>. Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 2007; 50: 1835-40.","DOI":"10.1016\/j.jacc.2007.03.071"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hata N, Seino Y, Tsutamoto T, <i>et al<\/i>. Effects of carperitide on the long-term prognosis of patients with acute decompensated chronic heart failure: the PROTECT multicenter randomized controlled study. Circ J 2008; 72: 1787-93.","DOI":"10.1253\/circj.CJ-08-0130"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. O&apos;Connor CM, Starling RC, Hernandez AF, <i>et al<\/i>. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365: 32-43.","DOI":"10.1056\/NEJMoa1100171"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. McMurray JJ, Packer M, Desai AS, <i>et al<\/i>. PARADIGM-HF Investigators and Committees. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 2014; 371: 993-1004.","DOI":"10.1056\/NEJMoa1409077"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Packer M, McMurray JJ, Desai AS, <i>et al<\/i>; PARADIGM-HF Investigators and Coordinators. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation 2015; 131: 54-61.","DOI":"10.1161\/CIRCULATIONAHA.114.013748"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lin X, H\u00e4nze J, Heese F, Sodmann R, Lang RE. Gene expression of natriuretic peptide receptors in myocardial cells. Circ Res 1995; 77: 750-8.","DOI":"10.1161\/01.RES.77.4.750"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Del Ry S, Cabiati M, Vozzi F, <i>et al<\/i>. Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes. Peptides 2011; 32: 1713-8.","DOI":"10.1016\/j.peptides.2011.06.014"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tsutamoto T, Wada A, Sakai H, <i>et al<\/i>. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 2006; 47: 582-6.","DOI":"10.1016\/j.jacc.2005.10.038"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tsutamoto T, Sakai H, Ishikawa C, <i>et al<\/i>. Direct comparison of transcardiac difference between increase brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure. Eur J Heart Fail 2007; 9: 667-73.","DOI":"10.1016\/j.ejheart.2007.01.003"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tsutamoto T, Sakai H, Nishiyama K, <i>et al<\/i>. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal pro-BNP and prognosis in patients with chronic heart failure 2007. Circ J 2007; 71: 1873-8.","DOI":"10.1253\/circj.71.1873"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Tsutamoto T, Kanamori T, Wada A, Kinoshita M. Uncoupling of atrial natriuretic peptide extraction and cyclic guanosine monophosphate production in the pulmonary circulation in patients with severe heart failure. J Am Coll Cardiol 1992; 20: 541-6.","DOI":"10.1016\/0735-1097(92)90005-8"},{"key":"23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/01.CIR.87.1.70","volume":"87","year":"1993","unstructured":"23. Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamaoka O, Kinoshita M. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation 1993; 87: 70-5.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Tsutamoto T, Kinoshita M, Ohbayashi Y, Wada A, Maeda Y, Adachi T. Plasma arteriovenous cGMP difference as a useful indicator of nitrate tolerance in patients with heart failure. Circulation 1994; 90: 823-9.","DOI":"10.1161\/01.CIR.90.2.823"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Singh G, Kuc RE, Maguire JJ, Fidock M, Davenport AP. Novel snake venom ligand Dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure. Circ Res 2006; 99: 183-90.","DOI":"10.1161\/01.RES.0000232322.06633.d3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nougu\u00e9 H, Pezel T, Picard F, <i>et al<\/i>. Effects of sacubitril\/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study. Eur J Heart Fail 2019; 21: 598-605.","DOI":"10.1002\/ejhf.1342"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Brainin P, Frestad D, Prescott E. The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease: A systematic review and meta-analysis. Int J Cardiol 2018; 254: 1-9.","DOI":"10.1016\/j.ijcard.2017.10.052"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/1\/61_19-379\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T22:47:23Z","timestamp":1580510843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/1\/61_19-379\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.19-379","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]}}}